Investment
Invested in Odola Labs, a company engineering recombinant hemoglobin variants for shelf-stable synthetic blood, in an Early Stage VC round.
Odola Labs
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Odola Labs
Paralos Bioscience
Tomorrow Inc.
Olden Labs
Medra
Sphinx Bio
Bluenote Health